These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 3158319)

  • 1. Vasodilative effect of nicorandil on coronary artery.
    Miyazaki Y; Ogawa K; Satake T; Sugiyama S; Ozawa T
    Arzneimittelforschung; 1985; 35(2):504-7. PubMed ID: 3158319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of K+ channel opening and stimulation of cyclic GMP in the vasorelaxant effects of nicorandil in isolated piglet pulmonary and mesenteric arteries: relative efficacy and interactions between both pathways.
    Pérez-Vizcaíno F; Cogolludo AL; Villamor E; Tamargo J
    Br J Pharmacol; 1998 Mar; 123(5):847-54. PubMed ID: 9535012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inotropic and coronary vasodilatory actions of the K-adenosine triphosphate channel modulator nicorandil in human tissue.
    Müller-Ehmsen J; Brixius K; Hoischen S; Schwinger RH
    J Pharmacol Exp Ther; 1996 Dec; 279(3):1220-8. PubMed ID: 8968344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relaxant effects of pinacidil, nicorandil, hydralazine and nifedipine as studied in the porcine coronary artery and guinea-pig taenia coli.
    Matsui K; Ogawa Y; Imai S
    Arch Int Pharmacodyn Ther; 1986 Sep; 283(1):124-33. PubMed ID: 2948465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of nicorandil on cytosolic calcium concentrations and on tension development in the rabbit femoral artery.
    Abe S; Nishimura J; Nakamura M; Kanaide H
    J Pharmacol Exp Ther; 1994 Feb; 268(2):762-71. PubMed ID: 8113988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The contribution of guanylate cyclase stimulation and K+ channel opening to nicorandil-induced vasorelaxation depends on the conduit vessel and on the nature of the spasmogen.
    Magnon M; Durand I; Cavero I
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1411-8. PubMed ID: 7908056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of 4-aminopyridine and tetraethylammonium on relaxant responses of isolated dog coronary arteries to 2-nicotinamidoethyl nitrate (SG-75).
    Sakanashi M; Rokutanda M; Takeo S; Higuchi M
    Jpn Heart J; 1982 Mar; 23(2):227-33. PubMed ID: 6210787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms underlying endothelium-dependent, nitric oxide- and prostanoid-independent relaxation in monkey and dog coronary arteries.
    Fujioka H; Ayajiki K; Shinozaki K; Toda N; Okamura T
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Nov; 366(5):488-95. PubMed ID: 12382080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relaxant effect of nicorandil on the tonic contraction of the canine large coronary artery induced by phorbol 12,13-dibutylate.
    Kuromaru O; Sakai K
    Arch Int Pharmacodyn Ther; 1995; 330(1):25-38. PubMed ID: 8849308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the new potassium channel opener JTV-506 on coronary vessels in vitro and in vivo.
    Hirata Y; Kanada A; Miyai H; Mabuchi Y; Aisaka K
    Arzneimittelforschung; 1999 Mar; 49(3):199-206. PubMed ID: 10219462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Responses of human, monkey and dog coronary arteries in vitro to carbocyclic thromboxane A2 and vasodilators.
    Toda N
    Br J Pharmacol; 1984 Oct; 83(2):399-408. PubMed ID: 6435709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of nicorandil on the conductive coronary artery of the dog.
    Imai S; Nakazawa M; Takeda K; Nakagawa Y; Katano Y; Tsukada T; Nabata H; Ushijima T
    J Cardiovasc Pharmacol; 1987; 10 Suppl 8():S10-6. PubMed ID: 2447415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regional differences in the vasorelaxant effects of nicorandil and amlodipine on isolated porcine coronary arteries.
    Tankó LB; Mikkelsen EO; Frøbert O; Bagger JP
    Fundam Clin Pharmacol; 1998; 12(1):50-7. PubMed ID: 9523184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The group at C2 of N-ethylnicotinamide determines the vasodilator potencies and mechanisms of action of nicorandil and its congeners in canine coronary arteries.
    Satoh K; Yamada H; Yoneyama F; Taira N
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Nov; 344(5):589-95. PubMed ID: 1839805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dilator effects of nicorandil on isolated perfused coronary arteries of humans.
    Sakaino N; Araki H; Nishi K
    Arch Int Pharmacodyn Ther; 1990; 306():100-5. PubMed ID: 2150166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual mechanism of the relaxing effect of nicorandil by stimulation of cyclic GMP formation and by hyperpolarization.
    Kukovetz WR; Holzmann S; Braida C; Pöch G
    J Cardiovasc Pharmacol; 1991 Apr; 17(4):627-33. PubMed ID: 1711631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of relaxant effects of nicorandil on the dog coronary artery.
    Imai S; Ushijima T; Nakazawa M; Nabata H; Sakai K
    Arch Int Pharmacodyn Ther; 1983 Oct; 265(2):274-82. PubMed ID: 6228201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contractile activity of human coronary arteries and human myocardium in vitro and their sensitivity to calcium entry blockade by nifedipine.
    Godfraind T; Finet M; Lima JS; Miller RC
    J Pharmacol Exp Ther; 1984 Aug; 230(2):514-8. PubMed ID: 6589392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mode of cerebral vasodilating action of KC-404 in isolated canine basilar artery.
    Ohashi M; Kito J; Nishino K
    Arch Int Pharmacodyn Ther; 1986 Apr; 280(2):216-29. PubMed ID: 3087305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trimethaphan is a direct arterial vasodilator and an alpha-adrenoceptor antagonist.
    Harioka T; Hatano Y; Mori K; Toda N
    Anesth Analg; 1984 Mar; 63(3):290-6. PubMed ID: 6142667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.